Synonyms:
Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN
UNII: WX8293WGLC

Pharmacology

Action Mechanism of Action Reference
INHIBITOR Angiopoietin-2 inhibitor PubMed PubMed

Indications

Mesh Heading Maximum Phase Mesh ID Reference
Macular Degeneration 2 D008268 ClinicalTrials
Neoplasms 1 D009369 ClinicalTrials

Cross References

Resources Reference
ChEMBL CHEMBL2108678
FDA SRS WX8293WGLC